Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Total Liabilities (2022 - 2025)

CervoMed (CRVO) has disclosed Total Liabilities for 9 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 20.03% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2025, up 20.03% year-over-year, with the annual reading at $4.7 million for FY2025, 20.03% up from the prior year.
  • Total Liabilities hit $4.7 million in Q4 2025 for CervoMed, up from $4.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $60.2 million in Q2 2022 to a low of $2.1 million in Q1 2023.
  • Historically, Total Liabilities has averaged $11.7 million across 4 years, with a median of $3.9 million in 2024.
  • Biggest five-year swings in Total Liabilities: tumbled 95.76% in 2023 and later surged 49.45% in 2024.
  • Year by year, Total Liabilities stood at $13.2 million in 2022, then tumbled by 80.27% to $2.6 million in 2023, then soared by 49.45% to $3.9 million in 2024, then increased by 20.03% to $4.7 million in 2025.
  • Business Quant data shows Total Liabilities for CRVO at $4.7 million in Q4 2025, $4.6 million in Q3 2025, and $4.6 million in Q2 2025.